US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern 
South Korea Leveraged Chip ETF Trading Plunges After New Rules 
U.S. Disrupts China-Linked Hacking Campaign Targeting Government Agencies 
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO 
US Sailor’s Father Detained by Immigration Authorities 
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix 
France Keeps Top Health Alert as Officials Brace for Another Heatwave 
Trump Orders Reduction in U.S.-South Korea Military Drills, Citing Kim Jong Un Ties 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse 
US Military Uses Laser to Shoot Down Cartel Drones at Mexico Border 
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations 
New Zealand Moves to Ban Social Media for Children Under 16 
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Trump Administration Moves to Strip ABA of Law School Accreditor Status 
SEC Proposes ‘Regulation Crypto Assets’ Framework for Crypto Fundraising 
Add as a preferred source on Google
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
